← Leaderboards
Blake Peterson
Ohio State University
$11,402,719
Attributed
$12,682,008
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,682,008 · 9
By mechanism
R01$6,276,008 · 3
K12$2,471,629 · 1
P20$2,367,422 · 2
RC1$1,000,000 · 1
P30$566,949 · 2
Top collaborators
- Sharyn D Baker3 shared
- Shuiying Hu3 shared
Most similar at Ohio State University
Same institution · by research overlap
- William G Blum$1,308,600
- Sharyn D Baker$10,060,478
- Shuiying Hu$2,114,418
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignIn VivoIn VitroBasePropertyGrantBiologicalLeadMolecularStructureBiologyProgramsUniversitiesResearch PersonnelCellsPeptidesSmall MoleculeEvaluationDisciplineLinkMolecular ProbesPathway InteractionsFluorophoreMediating
Grant awards (43)
Targeting neuronal transport to ameliorate vincristine neurotoxicity$652,168
R01 · FY2025 · CA
Shared Resource 10: Medicinal Chemistry (MCSR)$111,851
P30 · FY2025 · CA · contact PI
Targeting neuronal transport to ameliorate vincristine neurotoxicity$620,870
R01 · FY2024 · CA
Shared Resource 10: Medicinal Chemistry (MCSR)$113,773
P30 · FY2024 · CA · contact PI
Targeting neuronal transport to ameliorate vincristine neurotoxicity$645,896
R01 · FY2023 · CA
Shared Resource 10: Medicinal Chemistry (MCSR)$113,775
P30 · FY2023 · CA · contact PI
Shared Resource 10: Medicinal Chemistry (MCSR)$113,775
P30 · FY2022 · CA · contact PI
Synthetic Lethal Targeting of Growth Factor Receptors$356,850
R01 · FY2021 · CA · contact PI
Synthetic Chemical Biology$161,583
P20 · FY2021 · GM · contact PI
Shared Resource 10: Medicinal Chemistry (MCSR)$113,775
P30 · FY2021 · CA · contact PI
Synthetic Lethal Targeting of Growth Factor Receptors$356,850
R01 · FY2020 · CA · contact PI
Synthetic Chemical Biology$118,640
P20 · FY2020 · GM · contact PI
Synthetic Lethal Targeting of Growth Factor Receptors$318,172
R01 · FY2019 · CA · contact PI
Synthetic Chemical Biology$175,884
P20 · FY2019 · GM · contact PI
Synthetic Lethal Targeting of Growth Factor Receptors$328,587
R01 · FY2018 · CA · contact PI
Synthetic Chemical Biology$172,730
P20 · FY2018 · GM · contact PI
Synthetic Lethal Targeting of Growth Factor Receptors$329,148
R01 · FY2017 · CA · contact PI
Synthetic Chemical Biology$267,917
P20 · FY2017 · GM · contact PI
University of Kansas/Haskell Indian Nations University IRACDA Project$159,812
K12 · FY2017 · GM · contact PI
University of Kansas/Haskell Indian Nations University IRACDA Project$457,608
K12 · FY2016 · GM · contact PI
Synthetic Molecular Probes for In Vivo Imaging Core C$276,428
P20 · FY2016 · GM · contact PI
University of Kansas/Haskell Indian Nations University IRACDA Project$518,455
K12 · FY2015 · GM · contact PI
Synthetic Molecular Probes for In Vivo Imaging Core C$294,587
P20 · FY2015 · GM · contact PI
University of Kansas/Haskell Indian Nations University IRACDA Project$330,435
K12 · FY2014 · GM · contact PI
Synthetic Molecular Probes for In Vivo Imaging Core C$304,217
P20 · FY2014 · GM · contact PI
University of Kansas/Haskell Indian Nations University IRACDA Project$518,848
K12 · FY2013 · GM · contact PI
Synthetic Molecular Probes for In Vivo Imaging Core C$297,780
P20 · FY2013 · GM · contact PI
University of Kansas/Haskell Indian Nations University IRACDA Project$486,471
K12 · FY2012 · GM · contact PI
Synthetic Molecular Probes for In Vivo Imaging Core C$297,656
P20 · FY2012 · GM · contact PI
Synthetic Cell Surface Receptors for Anticancer Drug Delivery$232,058
R01 · FY2012 · CA · contact PI
Synthetic Cell Surface Receptors for Anticancer Drug Delivery$236,699
R01 · FY2011 · CA · contact PI
Tissue-specific delivery of probes by control of membrane trafficking of endoprot$500,000
RC1 · FY2010 · GM · contact PI
Synthetic Cell Surface Receptors for Anticancer Drug Delivery$243,882
R01 · FY2010 · CA · contact PI
Tissue-specific delivery of probes by control of membrane trafficking of endoprot$500,000
RC1 · FY2009 · GM · contact PI
Synthetic Cell Surface Receptors for Anticancer Drug Delivery$243,052
R01 · FY2009 · CA · contact PI
Cancer Therapeutics that Anchor Proteins to Membranes$231,902
R01 · FY2007 · CA · contact PI
Cancer Therapeutics that Anchor Proteins to Membranes$239,039
R01 · FY2006 · CA · contact PI
Cancer Therapeutics that Anchor Proteins to Membranes$245,001
R01 · FY2005 · CA
Cancer Therapeutics that Anchor Proteins to Membranes$243,463
R01 · FY2004 · CA
Cancer Therapeutics that Anchor Proteins to Membranes$227,412
R01 · FY2003 · CA
RECEPTOR MEMBRANE ANCHORING WITH SYNTHETIC ANTIESTROGENS$169,373
R01 · FY2002 · CA
RECEPTOR MEMBRANE ANCHORING WITH SYNTHETIC ANTIESTROGENS$164,438
R01 · FY2001 · CA
RECEPTOR MEMBRANE ANCHORING WITH SYNTHETIC ANTIESTROGENS$191,148
R01 · FY2000 · CA